Sarepta Gene Therapy Shipments

Order byBest matchMost fresh

Sarepta, Gene therapy

Roche pauses shipments of Elevidys gene therapy outside US

Roche Holding AG said on Tuesday it has paused all shipments of muscular disorder gene therapy Elevidys outside the U.S., echoing a similar decision by U.S. partner Sarepta Therapeutics on Tuesday.

· 9h

Sarepta Therapeutics says it will pause shipments of Duchenne gene therapy

· 3d · on MSN

Gene therapy maker Sarepta tells FDA it won’t halt shipments despite patient deaths

· 10h

Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy

Shares of drugmaker Sarepta Therapeutics continued to fall Tuesday after the company said it would comply with a Food and Drug Administration request to pause shipments of its gene therapy following s...

· 12h

Sarepta Faces Fresh Setback. Why Now’s Not the Time to Buy the Stock.

STAT · 15h

In surprise reversal, Sarepta Therapeutics says it will pause shipments of Duchenne gene therapy

Devdiscourse2h

Roche Pauses Shipments of Muscular Disorder Gene Therapy Elevidys Amid Safety Concerns

Roche Holding AG has temporarily halted shipments of the gene therapy Elevidys in some countries outside the U.S. following a similar move by U.S. partner Sarepta Therapeutics. The decision comes after the FDA requested a pause following the death of a patient undergoing the treatment.

BioSpace13h

Sarepta Concedes to FDA Request, Suspends US Shipments of Elevidys

After initially refusing to suspend Elevidys distribution after two deaths, Sarepta has now given in to the FDA’s request, noting the need to maintain a good working relationship with the regulator.